Lung Cancer and Heart Disease Risks Associated With Low-Dose Pulmonary Radiotherapy to COVID-19 Patients With Different Background Risks
Authors:
- 1 September 2021
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 111 (1) , 233-239
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (U19-AI067773)
This publication has 34 references indexed in Scilit:
- Low dose radiation therapy for COVID-19 pneumonia: A double-edged swordRadiotherapy and Oncology, 2020
- COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseasesRadiotherapy and Oncology, 2020
- Non-clinical radiation biology and pharmacology models: appraisal of state-of-the-art and innovationInternational Journal of Radiation Biology, 2019
- Radiation Dose-Response for Risk of Myocardial Infarction in Breast Cancer SurvivorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2019
- Incidence of Breast Cancer in the Life Span Study of Atomic Bomb Survivors: 1958–2009Radiation Research, 2018
- Lung, Laryngeal and Other Respiratory Cancer Incidence among Japanese Atomic Bomb Survivors: An Updated Analysis from 1958 through 2009Radiation Research, 2017
- Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast CancerNew England Journal of Medicine, 2013
- Anti-inflammatory effects of low-dose radiotherapyStrahlentherapie und Onkologie, 2012
- Radiation and Smoking Effects on Lung Cancer Incidence among Atomic Bomb SurvivorsRadiation Research, 2010
- Radiation Effects on Breast Cancer Risk: A Pooled Analysis of Eight CohortsRadiation Research, 2002